Episode

The Role of the CMO in BD and M&A Partnering with Pharma

Podcast: PharmaTalkRadio
Published: Dec 12, 2025
Duration seconds: 1670
Processing state: not_requested
Canonical source: https://www.spreaker.com/episode/the-role-of-the-cmo-in-bd-and-m-a-partnering-with-pharma--69004904
Audio: https://dts.podtrac.com/redirect.mp3/api.spreaker.com/download/episode/69004904/cmo_2025_bdma_podcast.mp3
JSON: /v1/public/podcasts/pharmatalkradio-7131046/episodes/the-role-of-the-cmo-in-bd-and-m-a-partnering-with-pharma
Markdown: /podcast/pharmatalkradio-7131046/the-role-of-the-cmo-in-bd-and-m-a-partnering-with-pharma.md

Actions

POST https://stenobird.com/v1/public/podcasts/pharmatalkradio-7131046/episodes/the-role-of-the-cmo-in-bd-and-m-a-partnering-with-pharma/transcription-requests
Idempotently request low-priority transcript generation for this episode.
GET https://stenobird.com/podcast/pharmatalkradio-7131046/the-role-of-the-cmo-in-bd-and-m-a-partnering-with-pharma.md
Read the agent-friendly Markdown representation of this episode resource.

Summary

In this podcast, featuring a panel discussion from the 2025 Chief Medical Officer Summit 360°, CMOs with recent M&A and partnership experience share those experiences as well as how CMOs of other small to midsize emerging biotech companies can support the conversations and operations that take place throughout the process of business development. Specifically: Different kinds of BD deals to be aware of How the CMO fits into various phases of transactions Appreciating how different c-suite colleagues and direct reports experience these transactions The different pharma teams CMOs will interact with What happens after the acquisition To learn more about the Chief Medical Officer Summit 360°, please visit CMO360.org .